08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
16
September 2025
In-Person Event | Hudson Institute
Hybrid Warfare and CCP Infiltration: A Shared Challenge for US-Taiwan Security Cooperation
Featured Speakers:
Sang Pu
KJ Hsu
Moderator:
Miles Yu
Getty Images
16
September 2025
In-Person Event | Hudson Institute
Hybrid Warfare and CCP Infiltration: A Shared Challenge for US-Taiwan Security Cooperation

Join Hudson Institute’s China Center as Dr. Miles Yu hosts a panel of experts and policymakers on how the US and its partners can strengthen security cooperation in defense of Taiwan.

Getty Images
Featured Speakers:
Sang Pu
KJ Hsu
Moderator:
Miles Yu
17
September 2025
In-Person Event | Hudson Institute
Motwani Jadeja US-India Dialogue Series: US-India Relations and the Defense COMPACT
Featured Speakers:
Vikram J. Singh
Anthony Renzulli
Dr. Sameer Lalwani
Ingrid Henick
Moderator:
Aparna Pande
Getty images
17
September 2025
In-Person Event | Hudson Institute
Motwani Jadeja US-India Dialogue Series: US-India Relations and the Defense COMPACT

Dr. Aparna Pande will host an expert panel to discuss how Washington and New Delhi can increase security collaboration to bolster security both bilaterally and multilaterally in the broader Indo-Pacific region.

Getty images
Featured Speakers:
Vikram J. Singh
Anthony Renzulli
Dr. Sameer Lalwani
Ingrid Henick
Moderator:
Aparna Pande
17
September 2025
In-Person Event | Hudson Institute
Industry, Security, and Community: Senator David McCormick on the Nippon Steel–U.S. Steel Deal
Featured Speakers:
Senator David McCormick
Hiroshi Ono
Kevin Lewis
Stefani Pashman
Moderators:
Joel Scanlon
William Chou
(Courtesy of U.S. Steel)
17
September 2025
In-Person Event | Hudson Institute
Industry, Security, and Community: Senator David McCormick on the Nippon Steel–U.S. Steel Deal

Experts talk about why this deal supports American workers and communities, the major capital and technological investment, and how Nippon Steel’s investment advances American industrial and economic strength.

(Courtesy of U.S. Steel)
Featured Speakers:
Senator David McCormick
Hiroshi Ono
Kevin Lewis
Stefani Pashman
Moderators:
Joel Scanlon
William Chou
15
September 2025
Past Event
Securing America’s Technological Edge: A Conversation with USPTO Acting Director Coke Morgan Stewart
Featured Speakers:
Coke Morgan Stewart
Adam Mossoff
Getty Images
15
September 2025
Past Event
Securing America’s Technological Edge: A Conversation with USPTO Acting Director Coke Morgan Stewart

Hudson’s Urška Petrovčič will host US Patent and Trademark Office Acting Director Coke Stewart to discuss patent rights’ vital role in advancing American competitiveness.

Getty Images
Featured Speakers:
Coke Morgan Stewart
Adam Mossoff